Jste zde


Overview of Clinical Trials Treating Cerebral Palsy with Cord Blood

Duben 2012
Frances Verter, PhD
Dr. Frances Verter

Frances Verter, PhD,
is the founder & director of
Parent's Guide to Cord
Blood Foundation

The vast majority of the media stories about cord blood therapy for cerebral palsy (CP) have been anecdotal reports of children who were treated by the group of Joanne Kurtzberg, MD, at Duke Medical Center. However, there are now multiple trials running around the world and more planned, so it is helpful to compare and contrast some of the trials. This overview is simply meant to be informative, not a comprehensive list or a rating of trials.

This type of therapy started because Dr. Kurtzberg noticed that children who were receiving cord blood transplants for hematologic disorders were displaying remarkable improvements in neurologic skills. In 2004 her group began giving autologous (their own) cord blood stem cells to young children who were diagnosed with various "acquired neurological disorders", a label that includes CP as well as other diagnoses such as anoxic brain injury, hypoxic brain injury, periventricular leukomalacia, encephalopathy, hydrocephalus, and in-utero stroke.

By the end of 2009, 184 children had been treated at Duke and were reported in a publication. Those cases showed that the procedure is safe, but there was no control group against which the efficacy of the treatment could be measured. The following clinical trials divide the patients into "arms", and each arm of the study receives a different treatment, enabling the effect of the treatments to be measured against each other.

In Korea, Minyoung Kim, MD PhD, is the lead investigator of a trial (NCT01193660) that has used allogeneic (donated) cord blood to treat 105 children with CP. The study ran from May 2010 to April 2011 and the results have been submitted for publication. The study had 3 arms: rehabilitation only, rehabilitation plus erythropoietin (a hormone that stimulates bone marrow to produce stem cells), and rehabilitation plus erythropoietin plus a matched cord blood donation. Since the effects of cord blood stem cells and erythropoietin are expected to be similar, that study is not likely to yield conclusive results about the efficacy of the cord blood infusion.

The table below compares another 4 trials that treat CP with cord blood. In all of these trials, the patients are divided into 2 arms. In those trials which enroll children who have stored their own autologous cord blood, both groups of children receive stem cells, but the difference between the two arms is whether the children receive their cells right away, or after a time delay. Basically the 2 arms test stem cells now versus later, and the length of the time delay varies between the trials. The study in which children receive donated allogeneic cord blood tests stem cells against a control without stem cells. To keep the patients blind as to who received stem cells, most trials give a "sham" infusion to the control group. In Australia, the ethics review board does not approve of subjecting children to sham infusions, so instead that study will emphasize double blind neurological assessments.

Hopefully, by 2013 or 2014 we will see the first publications from controlled trials that can measure the efficacy of cord blood for the treatment of cerebral palsy in young children.


Eligible DiagnosisCerebral PalsySpastic
Cerebral Palsy
Cerebral PalsyCerebral Palsy
Cord Blood
Stem Cells
InstitutionGeorgia Health Sciences University, USADuke University, USAMonash University, AustraliaSung Kwang Medical Foundation, Korea
InvestigatorsJames E Carroll
Roger A Vega
Elizabeth Sekul
Lloyd O Cook
Roni Bollag
Suzanne Strickland
Afshin Ameri
Joanne Kurtzberg
Jessica Sun
Suzie Miller
Michael Fahey
Euan Wallace
Minyoung Kim
Kyunghoon Min
Su Jin Jang
Jason Shim
Junyoung Song
Myung Seo Kang
Sang Heum Kim
ClinicalTrial.gov #NCT01072370NCT01147653PendingNCT01528436
Start DateJanuary 2010June 2010PendingFebruary 2012
Goal Enrollment401202040
Both arms get stem cells?YesYesYesNo
Delay between infusions3 months12 months6 monthsNone
Sham infusion?YesYesNoYes
Brain imaging?NoMRINoPET